Over the last year, 89bio’s stock has been somewhat volatile. Shares climbed past $10 earlier this year, but dropped under $6 ...

Access our live advanced streaming chart for Akero Therapeutics Inc stock, free of charge. This unique "area" or candle chart enables you to clearly notice the movements of this Akero Therapeutics ...

Introduced in FY23, Lupin Digital Health marked the company’s foray into the fast-growing digital therapeutics space. Its Lyfe platform focuses on real-time monitoring of patients and offers ...

If you own Akero Therapeutics, Inc. ("Akero") (NASDAQ:AKRO), please contact Fletcher Moore by email at [email protected] or (212) 709-8245. You may be able to seek monetary damages ...

If you own Akero Therapeutics, Inc. ("Akero") (NASDAQ:AKRO ), please contact Fletcher Moore by email at ... or (212) 709-8245. You may be able to seek monetary damages, corporate governance ...

Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by ...

Akero Therapeutics' EFX showed remarkable efficacy in reversing cirrhosis in the long-term SYMMETRY trial, a significant milestone in MASH treatment. EFX demonstrated consistent efficacy across ...

NEW YORK CITY, NY / ACCESS Newswire / April 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero" or "the ...

Piotr Swat / SOPA Images / LightRocket via Getty Images Some studies of Sarepta Therapeutics' muscular dystrophy drug, Elevidys, have been halted by European regulators after a patient taking it died.

Sarah Silbiger / Getty Images Shares of Aldeyra Therapeutics slumped nearly 75% to a record low on Thursday. The FDA told the drugmaker in a letter that its drug submitted to treat dry eye disease ...

It has been about a month since the last earnings report for Esperion Therapeutics (ESPR). Shares have lost about 15.8% in that time frame, underperforming the S&P 500. Will the recent negative ...

Akero Therapeutics Inc. (NASDAQ: AKRO) is a clinical-stage biopharmaceutical company also based near San Francisco. Shares soared earlier in the year on news of positive trial results for a liver ...